"Basal like Breast Cancer" trang 1 - tải miễn phí từ tailieunhanh
MiRNA-135b contributes to Triple Negative Breast Cancer molecular heterogeneity: Different expression profile in Basal-like versus non-Basal-like phenotypes

MiRNA-135b contributes to Triple Negative Breast Cancer molecular heterogeneity: Different expression profile in Basal-like versus non-Basal-like phenotypes
13    75    0
Feline mammary basal-like adenocarcinomas: A potential model for human triple-negative breast cancer (TNBC) with basal-like subtype

Feline mammary basal-like adenocarcinomas: A potential model for human triple-negative breast cancer (TNBC) with basal-like subtype
12    42    1
Integrative analysis of breast cancer profiles in TCGA by TNBC subgrouping reveals novel microRNA-specific clusters, including miR-17-92a, distinguishing basal-like 1 and basal-like 2 TNBC subtypes

Integrative analysis of breast cancer profiles in TCGA by TNBC subgrouping reveals novel microRNA-specific clusters, including miR-17-92a, distinguishing basal-like 1 and basal-like 2 TNBC subtypes
13    51    1
Claudin 1 expression in basal-like breast cancer is related to patient age

Claudin 1 expression in basal-like breast cancer is related to patient age
13    54    1
Inhibition of SHP2 in basal-like and triple-negative breast cells induces basal-to-luminal transition, hormone dependency, and sensitivity to anti-hormone treatment

Inhibition of SHP2 in basal-like and triple-negative breast cells induces basal-to-luminal transition, hormone dependency, and sensitivity to anti-hormone treatment
12    34    1
The suppression of DUSP5 expression correlates with paclitaxel resistance and poor prognosis in basal-like breast cancer

The suppression of DUSP5 expression correlates with paclitaxel resistance and poor prognosis in basal-like breast cancer
10    54    0
Antioxydation and cell migration genes are identified as potential therapeutic targets in basal-like and BRCA1 mutated breast cancer cell lines

Antioxydation and cell migration genes are identified as potential therapeutic targets in basal-like and BRCA1 mutated breast cancer cell lines
13    99    0
Comparative microRNA profiling of sporadic and BRCA1 associated basal-like breast cancers

Comparative microRNA profiling of sporadic and BRCA1 associated basal-like breast cancers
13    25    1
Clinicopathological study of centrally necrotizing carcinoma of the breast

Clinicopathological study of centrally necrotizing carcinoma of the breast
8    25    1
Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model

Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model
11    42    1
Wnt signaling in triple negative breast cancer is associated with metastasis

Wnt signaling in triple negative breast cancer is associated with metastasis
15    42    1
“Iron-saturated” bovine lactoferrin improves the chemotherapeutic effects of tamoxifen in the treatment of basal-like breast cancer in mice

“Iron-saturated” bovine lactoferrin improves the chemotherapeutic effects of tamoxifen in the treatment of basal-like breast cancer in mice
12    28    1
The unique transcriptional response produced by concurrent estrogen and progesterone treatment in breast cancer cells results in upregulation of growth factor pathways and switching from a Luminal A to a Basal-like subtype

The unique transcriptional response produced by concurrent estrogen and progesterone treatment in breast cancer cells results in upregulation of growth factor pathways and switching from a Luminal A to a Basal-like subtype
17    37    1
Analysis of breast cancer subtypes by AP-ISA biclustering

Analysis of breast cancer subtypes by AP-ISA biclustering
13    35    1
L1CAM is expressed in triple-negative breast cancers and is inversely correlated with Androgen receptor

L1CAM is expressed in triple-negative breast cancers and is inversely correlated with Androgen receptor
13    40    1